69 patients with DVT at least 1 week after acute symptoms was treated with streptokinase (Mean time 4 weeks after acute symptoms). Patients was divided for two groups: 1. with not entire main segments of deep vein occlusion and 2. with entire occlusion of segments of deep vein. Estimation of thrombolytic efficacy was performed by C. Theory. In the 1. group we achieved 23.8% of total obliteration and in 28.6% not entire. In the group 2. we achieved only 24.9% of partial obliteration. Intravenous streptokinase could be effective as well in long lasting deep vein thrombosis.
{"title":"[Results of thrombolytic therapy with streptokinase for chronic deep vein thrombosis].","authors":"J Kładny, G Szumiłowicz, P Gutowski, A Falkowski","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>69 patients with DVT at least 1 week after acute symptoms was treated with streptokinase (Mean time 4 weeks after acute symptoms). Patients was divided for two groups: 1. with not entire main segments of deep vein occlusion and 2. with entire occlusion of segments of deep vein. Estimation of thrombolytic efficacy was performed by C. Theory. In the 1. group we achieved 23.8% of total obliteration and in 28.6% not entire. In the group 2. we achieved only 24.9% of partial obliteration. Intravenous streptokinase could be effective as well in long lasting deep vein thrombosis.</p>","PeriodicalId":76332,"journal":{"name":"Polski tygodnik lekarski (Warsaw, Poland : 1960)","volume":"51 10-13","pages":"148-9"},"PeriodicalIF":0.0,"publicationDate":"1996-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19891626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Between 1990-1993 6 patients (4 females and 2 males) underwent the excision of the left atrial myxoma at The II Dept. of Cardiothoracic Surgery in Katowice. With the age range varying from 23 to 59 years. 3 patients presented symptoms of congestive heart failure with exertional dyspnoea, atrial fibrillation and syncope. 3 patients showed cerebral embolism. Every time the diagnosis was confirmed by the 2 D echocardiography. 4 patients were submitted the operation on the urgent basis because of occurring life threatening symptoms. All the patients were operated under cardiopulmonary bypass by the left atrial access, or in one case by the left and right atrial access simultaneously. The myxomas were removed and additionally the underlying endocardium or the full thickness of the interatrial septum, were excised. The surgical excision of the myxoma is the only acceptable therapy to cure. Without surgical treatment long term prognosis is fatal.
{"title":"[Nonpharmacologic treatment for heart arrhythmia].","authors":"F Walczak, E Koźluk","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Between 1990-1993 6 patients (4 females and 2 males) underwent the excision of the left atrial myxoma at The II Dept. of Cardiothoracic Surgery in Katowice. With the age range varying from 23 to 59 years. 3 patients presented symptoms of congestive heart failure with exertional dyspnoea, atrial fibrillation and syncope. 3 patients showed cerebral embolism. Every time the diagnosis was confirmed by the 2 D echocardiography. 4 patients were submitted the operation on the urgent basis because of occurring life threatening symptoms. All the patients were operated under cardiopulmonary bypass by the left atrial access, or in one case by the left and right atrial access simultaneously. The myxomas were removed and additionally the underlying endocardium or the full thickness of the interatrial septum, were excised. The surgical excision of the myxoma is the only acceptable therapy to cure. Without surgical treatment long term prognosis is fatal.</p>","PeriodicalId":76332,"journal":{"name":"Polski tygodnik lekarski (Warsaw, Poland : 1960)","volume":"51 10-13","pages":"159-62"},"PeriodicalIF":0.0,"publicationDate":"1996-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19891630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
In the blood of 20 patients with prostatic carcinoma the level of alpha 2-antiplasmin and plasminogen were examined. The control group consisted of 20 patients with benign prostatic hyperplasia. The low activity of alpha 2-antiplasmin in the blood of the patients with prostatic carcinoma was observed. The level of plasminogen was similar in both groups and it was in the low part of laboratory normal range. We concluded that the low levels of plasminogen and alpha 2-antiplasmin were a result of their consumption during activation of fibrinolysis process. The measurement of the alpha 2-antiplasmin and plasminogen can be useful to predict a risk of bleeding complications in the patients with prostatic carcinoma and benign prostatic hyperplasia.
{"title":"[Levels of plasminogen and alpha 2-antiplasmin in blood of patients with prostatic tumor].","authors":"Z Zietek, I Iwan-Zietek, M Kotschy, F Tyloch","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In the blood of 20 patients with prostatic carcinoma the level of alpha 2-antiplasmin and plasminogen were examined. The control group consisted of 20 patients with benign prostatic hyperplasia. The low activity of alpha 2-antiplasmin in the blood of the patients with prostatic carcinoma was observed. The level of plasminogen was similar in both groups and it was in the low part of laboratory normal range. We concluded that the low levels of plasminogen and alpha 2-antiplasmin were a result of their consumption during activation of fibrinolysis process. The measurement of the alpha 2-antiplasmin and plasminogen can be useful to predict a risk of bleeding complications in the patients with prostatic carcinoma and benign prostatic hyperplasia.</p>","PeriodicalId":76332,"journal":{"name":"Polski tygodnik lekarski (Warsaw, Poland : 1960)","volume":"51 6-9","pages":"86-8"},"PeriodicalIF":0.0,"publicationDate":"1996-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19730235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
I Iwan-Zietek, Z Zietek, M Kotschy, F Tyloch, A Szymański
We reported on a 74 year old patients with local advanced prostatic carcinoma. Following prostatic surgery an increased bleeding tendency was observed. The patients showed clinical and laboratory evidence for consumption coagulopathy with hyperfibrinolysis. The laboratory data were: marked decrease of AT III, Protein C, increase of thrombin/AT III complex level, fibrin degradation products (FDP) and antigen of t-PA. The treatment was ended successful.
{"title":"[Disseminated intravascular coagulation syndrome with secondary fibrinolysis activation in prostatic carcinoma].","authors":"I Iwan-Zietek, Z Zietek, M Kotschy, F Tyloch, A Szymański","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We reported on a 74 year old patients with local advanced prostatic carcinoma. Following prostatic surgery an increased bleeding tendency was observed. The patients showed clinical and laboratory evidence for consumption coagulopathy with hyperfibrinolysis. The laboratory data were: marked decrease of AT III, Protein C, increase of thrombin/AT III complex level, fibrin degradation products (FDP) and antigen of t-PA. The treatment was ended successful.</p>","PeriodicalId":76332,"journal":{"name":"Polski tygodnik lekarski (Warsaw, Poland : 1960)","volume":"51 6-9","pages":"100-1"},"PeriodicalIF":0.0,"publicationDate":"1996-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19730241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The study aims at evaluating an effect of hemodialyses duration on LH, FSH, and testosterone secretion in males with chronic renal insufficiency. Secretion of these hormones was assessed with LH-RH stimulation test in 41 men with chronic renal insufficiency and 15 healthy controls. Increased LH and FSH and decreased testosterone serum levels were seen in men with chronic renal insufficiency in comparison with healthy controls, independently of hemodialysis therapy duration. Duration of the treatment with hemodialyses has no significant effect on LH levels. Testosterone and FSH levels were significantly higher in patients treated over 50 months than those treated for shorter periods. Reactivity of LH secretion in LH-RH stimulation test was lower in patients dialysed for less than 100 months whereas in patients dialysed for over 100 months it was normal. Reactivity of testosterone secretion was higher in patients dialysed for over 50 months that those dialysed for shorter periods of time.
{"title":"[The effect of many years of hemodialysis therapy on hypophyseal-gonadal axis function in males with chronic renal insufficiency].","authors":"J Starzyk, W Grzeszczak","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The study aims at evaluating an effect of hemodialyses duration on LH, FSH, and testosterone secretion in males with chronic renal insufficiency. Secretion of these hormones was assessed with LH-RH stimulation test in 41 men with chronic renal insufficiency and 15 healthy controls. Increased LH and FSH and decreased testosterone serum levels were seen in men with chronic renal insufficiency in comparison with healthy controls, independently of hemodialysis therapy duration. Duration of the treatment with hemodialyses has no significant effect on LH levels. Testosterone and FSH levels were significantly higher in patients treated over 50 months than those treated for shorter periods. Reactivity of LH secretion in LH-RH stimulation test was lower in patients dialysed for less than 100 months whereas in patients dialysed for over 100 months it was normal. Reactivity of testosterone secretion was higher in patients dialysed for over 50 months that those dialysed for shorter periods of time.</p>","PeriodicalId":76332,"journal":{"name":"Polski tygodnik lekarski (Warsaw, Poland : 1960)","volume":"51 6-9","pages":"79-81"},"PeriodicalIF":0.0,"publicationDate":"1996-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19730233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}